VR Logo

Apollo Endosurgery Inc. (APEN) download report


Healthcare | Medical Devices & Equipment

Apollo Endosurgery Inc. (APEN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices.

IPO Date: 09-Dec-2005

CEO, Pres & Director: Mr. Charles S. McKhann

CFO, Sec. & Treasurer: Mr. Jeffrey G. Black

Listing: NASDAQ: APEN

Country: United States

Headquarters: Austin, TX

Website: https://www.apolloendo.com

Key Facts

Market cap: $146.91 Mln

Revenue (TTM): $65.79 Mln

Earnings (TTM): $-28.50 Mln

Cash: $81.73 Mln

Total Debt: $53.74 Mln

Insider's Holding: 7.35%

Liquidity: Low

52 Week range: $3.51 - 10.39

Shares outstanding: 40,250,400

10 Years Aggregate:

  • CFO: $-158.75 Mln
  • EBITDA: $-146.68 Mln
  • Net Profit: $-224.85 Mln

Stock Performance

Time Period Apollo Endosurgery (APEN) S&P BSE Sensex* S&P Small-Cap 600*
YTD-56.70-9.18-19.27
1 month-21.84-4.78-8.56
3 months-42.52-9.66-14.18
1 Year-57.060.81-17.70
3 Years3.9410.335.88
5 Years-13.8211.345.74
10 Years-37.5511.749.77
As on 30-Jun-2022 *As on 01-Jul-2022
Year Apollo Endosurgery (APEN) S&P Small-Cap 600 S&P BSE Sensex
2021147.9425.2721.99
202019.309.5715.75
2019-17.3920.8614.38
2018-38.23-9.705.87
2017-53.9511.7327.91
2016-30.4624.741.95
2015-91.95-3.36-5.03